RLAY — Relay Therapeutics Share News
0.000.00%
Last trade - 00:00- $3.79bn
- $2.88bn
- $15.36m
Relay Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Relay Therapeutics Q2 revenue misses estimates on higher R&D expenses; net loss widens
Brief: Relay Therapeutics Q2 Net Income USD -83.707 Million Vs. IBES Estimate USD -74.2 Million
U.S. RESEARCH ROUNDUP- Alliant Energy, Prog Holdings, Travelers
U.S. STOCKS ON THE MOVE-Moderna, Kontoor Brands, Ralph Lauren
U.S. STOCKS ON THE MOVE- Intuit, Deere, Advance Auto Parts
U.S. STOCKS ON THE MOVE-Keysight Technologies, Relay Therapeutics, Ralph Lauren
Relay Therapeutics gains after $275 mln equity raise
Brief: Relay Therapeutics Announces Pricing Of Public Offering Of Common Stock
Relay jumps on promising vascular disorder drug data
U.S. RESEARCH ROUNDUP- CAVA Group, Eagle Materials, Vertiv Holdings
Relay Therapeutics drops on $175 mln stock offering
U.S. STOCKS ON THE MOVE- Hims & Hers Health, Driven Brands, Onto Innovation
U.S. STOCKS ON THE MOVE-T1 Energy, Home Depot, X-Energy
U.S. STOCKS ON THE MOVE-Nvidia, SiTime Corp, Hoth Therapeutics
U.S. STOCKS ON THE MOVE-Alphabet, Relay Therapeutics, Amer Sports
Relay Therapeutics rises after vascular disorder drug shows promise in study
Relay's treatment shown to shrink vascular malformations in mid-stage trial (updated)
Brief: Relay Therapeutics Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential For Differentiated Safety And Efficacy In Patients With PIK3CA-Driven Vascular Anomalies